{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:08:51Z","timestamp":1791828531719,"version":"4.3.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR241-TP-C03"],"award-info":[{"award-number":["TRR241-TP-C03"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2318-TP-C03"],"award-info":[{"award-number":["GRK2318-TP-C03"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001610","name":"Falk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health at Charit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.gastro.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:02:51Z","timestamp":1707782571000},"page":"183-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Look Into the Future: Are We Ready for an Approved Therapy in Celiac Disease?"],"prefix":"10.1053","volume":"167","author":[{"given":"Robert P.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2024.02.005_bib1","series-title":"US Food and Drug Administration. Guidance Document. Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet","year":"2022"},{"key":"10.1053\/j.gastro.2024.02.005_bib2","unstructured":"Dailymed. Dapsone tablet. Available at: https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=0792169d-c6f9-4af0-93ae-b75d710c47a9. Accessed December 18, 2023."},{"key":"10.1053\/j.gastro.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/nu10111796","article-title":"Gluten-free diet in celiac disease-forever and for all?","volume":"10","author":"Itzlinger","year":"2018","journal-title":"Nutrients"},{"key":"10.1053\/j.gastro.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(01)05554-4","article-title":"Mortality in patients with coeliac disease and their relatives: a cohort study","volume":"358","author":"Corrao","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0016-5085(89)90060-7","article-title":"Mortality in celiac disease","volume":"97","author":"Logan","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jama.2020.1943","article-title":"Association between celiac disease and mortality risk in a Swedish population","volume":"323","author":"Lebwohl","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-277X.2007.00763.x","article-title":"Economic burden of a gluten-free diet","volume":"20","author":"Lee","year":"2007","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1053\/j.gastro.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/jhn.12375","article-title":"Coeliac disease and the gluten-free diet: a review of the burdens; factors associated with adherence and impact on health-related quality of life, with specific focus on adolescence","volume":"29","author":"White","year":"2016","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1053\/j.gastro.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-277X.2008.00867.x","article-title":"The everyday life of adolescent coeliacs: issues of importance for compliance with the gluten-free diet","volume":"21","author":"Olsson","year":"2008","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1053\/j.gastro.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2009.04053.x","article-title":"Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease","volume":"30","author":"Hall","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jhn.12597","article-title":"Experiences of coeliac disease in a changing gluten-free landscape","volume":"32","author":"King","year":"2019","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1053\/j.gastro.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/MPG.0000000000002605","article-title":"Mental health disorders and psychosocial distress in pediatric celiac disease","volume":"70","author":"Coburn","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrgastro.2015.155","article-title":"Mechanisms and management of refractory coeliac disease","volume":"12","author":"van Gils","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/gutjnl-2023-329751","article-title":"Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients","volume":"72","author":"Schiepatti","year":"2023","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.02.005_bib16","first-page":"519","article-title":"The gluten-free diet: a nutritional risk factor for adolescents with celiac disease?","volume":"27","author":"Mariani","year":"1998","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000369504","article-title":"Celiac disease and the gluten-free diet: consequences and recommendations for improvement","volume":"33","author":"Theethira","year":"2015","journal-title":"Dig Dis"},{"key":"10.1053\/j.gastro.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2036.2010.04386.x","article-title":"Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet","volume":"32","author":"Wild","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.02.005_bib19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1046\/j.1365-2036.2002.01283.x","article-title":"Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years","volume":"16","author":"Hallert","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000348850","article-title":"Inadequate nutrient intake in patients with celiac disease: results from a German dietary survey","volume":"87","author":"Martin","year":"2013","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jhn.12018","article-title":"Nutritional inadequacies of the gluten-free diet in both recently-diagnosed and long-term patients with coeliac disease","volume":"26","author":"Shepherd","year":"2013","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1053\/j.gastro.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3390\/nu15092048","article-title":"Follow-up of celiac disease in adults: \"when, what, who, and where.\"","volume":"15","author":"Mulder","year":"2023","journal-title":"Nutrients"},{"key":"10.1053\/j.gastro.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/00365528509089626","article-title":"Non-tropical sprue. Malignant diseases and mortality rate","volume":"20","author":"Nielsen","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.cgh.2009.07.031","article-title":"A\u00a0validated disease-specific symptom index for adults with celiac disease","volume":"7","author":"Leffler","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2008.12.032","article-title":"A\u00a0simple validated gluten-free diet adherence survey for adults with celiac disease","volume":"7","author":"Leffler","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib26","doi-asserted-by":"crossref","unstructured":"Elli L, Leffler D, Cellier C, et\u00a0al. Guidelines for best practices in monitoring established coeliac disease in adult patients. Nat Rev Gastroenterol Hepatol 2024;21:198\u2013215.","DOI":"10.1038\/s41575-023-00872-2"},{"key":"10.1053\/j.gastro.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1136\/gutjnl-2020-320593","article-title":"To biopsy or not to biopsy: that is the question","volume":"72","author":"Murray","year":"2023","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/gutjnl-2015-310148","article-title":"Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing","volume":"66","author":"Moreno","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2022","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.02.005_bib30","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000639","article-title":"Serological investigation of persistent villous atrophy in celiac disease","volume":"14","author":"Gong","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","article-title":"Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease","volume":"126","author":"Verbeek","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.gastro.2020.10.040","article-title":"Evaluating responses to gluten challenge: a randomized, double-blind, 2-dose gluten challenge trial","volume":"160","author":"Leonard","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","article-title":"European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020","volume":"70","author":"Husby","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gutjnl-2020-320913","article-title":"Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts","volume":"70","author":"Penny","year":"2021","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.02.005_bib35","unstructured":"Centers for Medicare & Medicaid Services. CLIA overview. Available at: https:\/\/www.cms.gov\/regulations-and-guidance\/legislation\/clia\/downloads\/ldt-and-clia_faqs.pdf. Accessed December 18, 2023."},{"key":"10.1053\/j.gastro.2024.02.005_bib36","unstructured":"Federal Register. Food labeling; gluten-free labeling of foods. Available at: https:\/\/www.federalregister.gov\/documents\/2013\/08\/05\/2013-18813\/food-labeling-gluten-free-labeling-of-foods. Accessed December 18, 2023."},{"key":"10.1053\/j.gastro.2024.02.005_bib37","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/ctg.2015.48","article-title":"Prior misdiagnosis of celiac disease is common among patients referred to a tertiary care center: a prospective cohort study","volume":"7","author":"Ianiro","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cei.13578","article-title":"Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease","volume":"204","author":"Anderson","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/2050640614540154","article-title":"Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge","volume":"2","author":"Christophersen","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2024.02.005_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734763","article-title":"Circulating miRNAs as potential biomarkers for celiac disease development","volume":"12","author":"Tan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/2050640619874173","article-title":"Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity","volume":"8","author":"Tye-Din","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/00365521.2013.777470","article-title":"Prevalence and natural history of potential celiac disease in adult patients","volume":"48","author":"Biagi","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/apt.12621","article-title":"Predictors of persistent villous atrophy in coeliac disease: a population-based study","volume":"39","author":"Lebwohl","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2024.02.005_bib44","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2468-1253(22)00428-9","article-title":"Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study","volume":"8","author":"Tye-Din","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ajg.2017.480","article-title":"Measuring change in small intestinal histology in patients with celiac disease","volume":"113","author":"Adelman","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib46","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.cgh.2022.01.011","article-title":"A\u00a0low FODMAP diet reduces symptoms in treated celiac patients with ongoing symptoms-a randomized controlled trial","volume":"20","author":"van Megen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib47","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3748\/wjg.v18.i12.1348","article-title":"Celiac disease: management of persistent symptoms in patients on a gluten-free diet","volume":"18","author":"Dewar","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib48","unstructured":"US Food and Drug Administration. Understanding unapproved use of approved drugs \"off label.\" Available at: https:\/\/www.fda.gov\/patients\/learn-about-expanded-access-and-other-treatment-options\/understanding-unapproved-use-approved-drugs-label. Accessed December 18, 2023."},{"key":"10.1053\/j.gastro.2024.02.005_bib49","unstructured":"US Food and Drug Administration. FDA 1010: dietary supplements. Available at: https:\/\/www.fda.gov\/consumers\/consumer-updates\/fda-101-dietary-supplements. Accessed December 18, 2023."},{"key":"10.1053\/j.gastro.2024.02.005_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/metabo13010074","article-title":"The effect of a gluten-free diet on vitamin D metabolism in celiac disease: the state of the art","volume":"13","author":"Di Stefano","year":"2023","journal-title":"Metabolites"},{"key":"10.1053\/j.gastro.2024.02.005_bib51","first-page":"313","article-title":"Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients","volume":"92","author":"Mautalen","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1572-0241.2001.03616.x","article-title":"Vitamin B12 deficiency in untreated celiac disease","volume":"96","author":"Dahele","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1756283X17690991","article-title":"Commercially available glutenases: a potential hazard in coeliac disease","volume":"10","author":"Krishnareddy","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib54","series-title":"Guidance for health practitioners accessing unapproved therapeutic goods, version 1.0","year":"2023"},{"key":"10.1053\/j.gastro.2024.02.005_bib55","first-page":"e2118","article-title":"Addition of a short course of prednisolone to a gluten-free diet vs. gluten-free diet\u00a0alone in recovery of celiac disease: a pilot randomized controlled trial","volume":"10","author":"Abbas","year":"2018","journal-title":"Cureus"},{"key":"10.1053\/j.gastro.2024.02.005_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gut.11.1.7","article-title":"Response of the jejunal mucosa in adult coeliac disease to oral prednisolone","volume":"11","author":"Wall","year":"1970","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2024.02.005_bib57","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MPG.0000000000003596","article-title":"Budesonide and the gluten containing elimination diet as treatments for non-responsive celiac disease in children","volume":"75","author":"Ali Ibrahim","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2024.02.005_bib58","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s10620-020-06454-5","article-title":"Enteric-release budesonide may be useful in the management of non-responsive celiac disease","volume":"66","author":"Therrien","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2024.02.005_bib59","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","volume":"112","author":"Mukewar","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.02.005_bib61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S2468-1253(23)00107-3","article-title":"Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial","volume":"8","author":"Murray","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661622","article-title":"A\u00a0sensitive whole blood assay detects antigen-stimulated cytokine release from CD4+ T cells and facilitates immunomonitoring in a phase 2 clinical trial of Nexvax2 in coeliac disease","volume":"12","author":"Hardy","year":"2021","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib64","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2024.02.005_bib65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MPG.0000000000003540","article-title":"ESPGHAN position paper on management and follow-up of children and adolescents with celiac disease","volume":"75","author":"Mearin","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2024.02.005_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jadohealth.2013.08.009","article-title":"Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review","volume":"54","author":"Hanghoj","year":"2014","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1053\/j.gastro.2024.02.005_bib67","first-page":"67","article-title":"The gluten free diet: assessing adherence in a pediatric celiac disease population","volume":"3","author":"Dowhaniuk","year":"2020","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"key":"10.1053\/j.gastro.2024.02.005_bib68","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPG.0000000000001873","article-title":"Adherence to the gluten-free diet and health-related quality of life in an ethnically diverse pediatric population with celiac disease","volume":"66","author":"Mager","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2024.02.005_bib69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1037\/fsh0000099","article-title":"Celiac is a social disease: family challenges and strategies","volume":"33","author":"Bacigalupe","year":"2015","journal-title":"Fam Syst Health"},{"key":"10.1053\/j.gastro.2024.02.005_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1710-1492-10-57","article-title":"Two year effects of food allergen immunotherapy on quality of life in caregivers of children with food allergies","volume":"10","author":"Arasi","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib71","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2018.06.016","article-title":"Quality of life of food-allergic patients before, during, and after oral immunotherapy","volume":"7","author":"Epstein-Rigbi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1053\/j.gastro.2024.02.005_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1710-1492-10-25","article-title":"Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects","volume":"10","author":"Otani","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib73","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1517\/17425255.2015.1065813","article-title":"Theoretical pharmacokinetic drug alterations in pediatric celiac disease","volume":"11","author":"Tran","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1053\/j.gastro.2024.02.005_bib74","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1542\/peds.2010-0082","article-title":"Clinical report\u2014guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations","volume":"125","author":"Shaddy","year":"2010","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2024.02.005_bib75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mayocp.2016.10.012","article-title":"Less hidden celiac disease but increased gluten avoidance without a diagnosis in the United States: findings from the National Health and Nutrition Examination Surveys from 2009 to 2014","volume":"92","author":"Choung","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2024.02.005_bib76","first-page":"100","article-title":"How often do hematologists consider celiac disease in iron-deficiency anemia? Results of a national survey","volume":"12","author":"Smukalla","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1053\/j.gastro.2024.02.005_bib77","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1747493018778713","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE)","year":"2018","journal-title":"Int J Stroke"},{"key":"10.1053\/j.gastro.2024.02.005_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathmechdis-031521-032634","article-title":"The immunobiology and pathogenesis of celiac disease","volume":"18","author":"Iversen","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1053\/j.gastro.2024.02.005_bib79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00251-019-01141-w","article-title":"Update 2020: nomenclature and listing of celiac disease-relevant gluten epitopes recognized by CD4(+) T cells","volume":"72","author":"Sollid","year":"2020","journal-title":"Immunogenetics"},{"key":"10.1053\/j.gastro.2024.02.005_bib80","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0198-8859(03)00027-2","article-title":"HLA types in celiac disease patients not carrying the DQA1\u221705-DQB1\u221702 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease","volume":"64","author":"Karell","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.immuni.2007.05.015","article-title":"A\u00a0structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease","volume":"27","author":"Henderson","year":"2007","journal-title":"Immunity"},{"key":"10.1053\/j.gastro.2024.02.005_bib82","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1073\/pnas.1914308117","article-title":"A\u00a0molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease","volume":"117","author":"Ting","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2024.02.005_bib83","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12916-020-01828-y","article-title":"Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease","volume":"18","author":"Tye-Din","year":"2020","journal-title":"BMC Med"},{"key":"10.1053\/j.gastro.2024.02.005_bib84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.13369","article-title":"Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease","volume":"199","author":"Goel","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2024.02.005_bib85","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Guidelines. Available at: https:\/\/www.ich.org\/. Accessed December 18, 2023."},{"key":"10.1053\/j.gastro.2024.02.005_bib86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ajcn\/nqx049","article-title":"Determination of gluten consumption in celiac disease patients on a gluten-free diet","volume":"107","author":"Syage","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2024.02.005_bib87","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41467-022-28353-1","article-title":"An efficient urine peptidomics workflow identifies chemically defined dietary gluten peptides from patients with celiac disease","volume":"13","author":"Palanski","year":"2022","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2024.02.005_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ygh2.380","article-title":"Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten-free diet","volume":"2","author":"Daveson","year":"2020","journal-title":"GastroHep"},{"key":"10.1053\/j.gastro.2024.02.005_bib89","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.gastro.2020.04.018","article-title":"Evidence that\u00a0pathogenic transglutaminase 2 in celiac disease derives from enterocytes","volume":"159","author":"Iversen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2024.02.005_bib90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A\u00a0randomized trial of a transglutaminase 2 inhibitor for celiac disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2024.02.005_bib91","first-page":"S49","article-title":"Review article: follow-up of coeliac disease","volume":"56","author":"Tye-Din","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2024.02.005_bib92","first-page":"S18","article-title":"Review article: diagnosis of coeliac disease: a perspective on current and future approaches","volume":"56","author":"Anderson","year":"2022","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524001677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508524001677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:15:20Z","timestamp":1777407320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508524001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0016508524001677"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2024.02.005","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Look Into the Future: Are We Ready for an Approved Therapy in Celiac Disease?","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}